🇺🇸 FDA
Patent

US 7482489

Enantiomerically pure (R)-albuterol dibenzoyltartrate and protected analogs thereof

granted A61PA61P11/00A61P11/06

Quick answer

US patent 7482489 (Enantiomerically pure (R)-albuterol dibenzoyltartrate and protected analogs thereof) held by Teva Pharmaceutical Fine Chemicals S.R.L. expires Mon Jan 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Teva Pharmaceutical Fine Chemicals S.R.L.
Grant date
Tue Jan 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61P, A61P11/00, A61P11/06, A61P11/08, A61P43/00